- Flt3 ligand synergizes with granulocyte-colony-stimulating factor in bone marrow mobilization to improve functional outcome after spinal cord injury in the rat2011 | Second Faculty of Medicine, Central Library of Charles University
- Live cell vaccines expressing B7.1, monocyte chemoattractant protein 1 and granulocyte-macrophage colony stimulation factor derived from mouse HPV16-transformed cells2008 | Second Faculty of Medicine
- Properties of bcr-abl-transformed mouse 12B1 cells secreting interleukin-2 and granulocyte-macrophage colony stimulating factor (GM-CSF): II. Adverse effects of GM-CSF2012 | First Faculty of Medicine, Third Faculty of Medicine
- Implications of the European Organisation for Research And Treatment Of Cancer (EORTC) guidelines on the use of granulocyte colony-stimulating factor (G-CSF) for lymphoma care2009 | First Faculty of Medicine
- Prophylactic human granulocyte colony-stimulating factor after induction therapy in pediatric acute myeloid leukemia2007 | Second Faculty of Medicine
- Collection of stem cells using granulocyte-colony-stimulating factor in chronic myeloid leukemia patients treated with Glivec +1Publication without faculty affiliation
- Transplantation of bone marrow stem cells as well as mobilization by granulocyte-colony stimulating factor promotes recovery after spinal cord injury in rats2006 | Second Faculty of Medicine
- Less toxicity by optimizing chemotherapy, but not by addition of granulocyte colony-stimulating factor in children and adolescents with acute myeloid leukemia: Results of AML-BFM 982006 | Second Faculty of Medicine
- Activation of adenosine A(3) receptors supports hematopoiesis-stimulating effects of granulocyte colony-stimulating factor in sublethally irradiated mice2010 | First Faculty of Medicine
- Randomized Trial of Prophylactic Granulocyte Colony-Stimulating Factor During Rapid COJEC Induction in Pediatric Patients With High-Risk Neuroblastoma: The European HR-NBL1/SIOPEN Study2010 | Second Faculty of Medicine
- Granulocyte Colony-Stimulating Factor (G-CSF) Treatment of Childhood Acute Myeloid Leukemias That Overexpress the Differentiation-Defective G-CSF Receptor Isoform IV Is Associated With a Higher Incidence of Relapse2010 | Second Faculty of Medicine
- A Case Report: Neutropenia Grade IV and Febrile Neutropenia in a Metastatic Breast Cancer Patient Treated With Palliative Chemotherapy Cyclophosphamide/Myocet2013 | Faculty of Medicine in Hradec Králové
- OPERa Study2013 | First Faculty of Medicine
- Cobalt protoporphyrin IX increases endogenous G-CSF and mobilizes HSC and granulocytes to the blood2019 | First Faculty of Medicine
- Outcome and management of pregnancies in severe chronic neutropenia patients by the European branch of the severe chronic neutropenia international registry2014 | Publication without faculty affiliation
- Individually determined dosing of filgrastim after autologous peripheral stem cell transplantation in patients with malignant lymphoma -results of a prospective multicentre controlled trial2006 | First Faculty of Medicine, Third Faculty of Medicine, Faculty of Physical Education and Sport
- G-CSF plus azacitidine versus azacitidine alone for patients with high-risk myelodysplastic syndrome: academic, open label, randomized trial2022 | First Faculty of Medicine, Faculty of Mathematics and Physics
- The increase of the rate of hemopoietic recovery and clinical benefit of the erytropoietin (EPO) and granulocyte colony-stimulating factor (G-CSF) with peripheral blood progenitor cells (PBPC) after intensive cyclic chemotherapy in high-risk breast cancer patients1999 | Faculty of Medicine in Hradec Králové
- C/EBP gamma is dispensable for steady-state and emergency granulopoiesis2018 | Second Faculty of Medicine, Faculty of Science
- Plerixafor combined with standard regimens for hematopoietic stem cell mobilization in pediatric patients with solid tumors eligible for autologous transplants: two-arm phase I/II study (MOZAIC)2020 | Second Faculty of Medicine
- Hematopoietic cells expressing the peripheral cannabinoid receptor migrate in response to the endocannabinoid 2-arachidonoylglycerol2002 | Central Library of Charles University
- 5-Azacitidine in aggressive myelodysplastic syndromes regulates chromatin structure at PU.1 gene and cell differentiation capacity2012 | First Faculty of Medicine
- The peripheral cannabinoid receptor Cb2, a novel oncoprotein, induces a reversible block in neutrophilic differentiation2003 | Central Library of Charles University
- Comparison of horse and rabbit antithymocyte globulin in immunosuppressive therapy for refractory cytopenia of childhood2014 | Second Faculty of Medicine
- Stem Cell. Therapy for Amyotrophic Lateral Sclerosis - an Overview of Current Clinical Experience2017 | Second Faculty of Medicine
- Disruption of the C/EBPα-miR-182 balance impairs granulocytic differentiation2017 | Central Library of Charles University
- The peripheral cannabinoid receptor Cb2, frequently expressed on AML blasts, either induces a neutrophilic differentiation block or confers abnormal migration properties in a ligand-dependent manner2004 | Central Library of Charles University
- Germline CBL mutations cause developmental abnormalities and predispose to juvenile myelomonocytic leukemia2010 | Second Faculty of Medicine
- Adjusting the Chemical and Physical Properties of Hydrogels Leads to Improved Stem Cell Survival and Tissue Ingrowth in Spinal Cord Injury Reconstruction: A Comparative Study of Four Methacrylate Hydrogels2013 | First Faculty of Medicine, Faculty of Physical Education and Sport, Second Faculty of Medicine